By Billion Photos @ Shutterstock.com
At Mercola.com, Dr. Joseph Mercola warns readers about iDNA vaccines, which he describes as “like mRNA, but on steroids.” He writes:
If you thought mRNA injections were the craziest things the vaccine industry has cooked up lately, you haven’t seen the half of it yet. Up next, we have so-called “immunization DNA” or iDNA,1,2 a novel class of gene therapy “vaccines” that encodes for the whole virus.
It’s like mRNA, but on steroids. Rather than instructing your cells to produce a small portion, the spike protein of a given virus, iDNA products instruct cells to produce the virus in its entirety. As described in U.S. Patent 8691563B2:3
“The iDNA generates live attenuated vaccines in eukaryotic cells in vitro or in vivo for pathogenic RNA viruses … When iDNA is injected into the vaccine recipient, RNA of live attenuated virus is generated by in vivo transcription in the recipient’s tissues.
This initiates production of progeny attenuated viruses in the tissues of the vaccine recipient, as well as elicitation of an effective immune response protecting against wild-type, non-attenuated virus.”
According to Taipei-based Medigen,4 which launched its iDNA “vaccine” platform in 2018, the technology “combines genetic stability of DNA with the exceptional efficacy of live attenuated vaccines.” “Live attenuated” vaccines refers to vaccines that contain live (viable) but weakened (less virulent) viruses.
The iDNA platform can be used to create vaccines in two different ways. You can either grow the iDNA in a culture to produce the vaccine in the conventional way, or you can inject the iDNA directly into the recipient and allow the body to produce the live attenuated virus internally.
What Could Go Wrong?
A 2016 paper described the iDNA process thus:5
“As any DNA vaccine, iDNA plasmids are isolated from bacteria and include a eukaryotic promoter, such as cytomegalovirus (CMV) major immediate-early promoter.
However, unlike a traditional DNA vaccine that involves transcription of mRNA for expression of a subunit antigen, the iDNA vaccines transcribe the full-length genomic RNA of the live-attenuated vaccine virus. The full-length viral RNA then initiates limited replication of live-attenuated virus in the tissues of vaccine recipient resulting in efficient immunization.
Essentially, the iDNA plasmid turns a limited number of cells in the vaccine recipient into the cell-scale factories for ‘manufacturing’ of live-attenuated vaccine.
Thus, the iDNA technology represents a novel type of DNA vaccine. With the introduction of DNA-launched iDNA vaccines, DNA-based vaccines can be subdivided into (i) DNA vaccines that express subunit antigens and (ii) DNA vaccines that launch replication-competent, live-attenuated vaccines …
Finally, the iDNA plasmid can be used as a genetically stable repository seed to prepare live-attenuated virus in vitro either for subsequent use as a traditional live-attenuated vaccine or, after virus inactivation, as a traditional inactivated virus vaccine.”
Oh joy. Considering the shocking harms mRNA injections are causing, which instruct your body to create just a small portion of a virus that has no capacity to self-replicate, what could conceivably happen if we start injecting DNA that causes your cells to churn out replication-competent live virus?
Read more here.
If you’re willing to fight for Main Street America, click here to sign up for the Richardcyoung.com free weekly email.
